Next Article in Journal
Frailty Intervention through Nutrition Education and Exercise (FINE). A Health Promotion Intervention to Prevent Frailty and Improve Frailty Status among Pre-Frail Elderly—A Study Protocol of a Cluster Randomized Controlled Trial
Previous Article in Journal
Comparison between Percutaneous Gastrostomy and Self-Expandable Metal Stent Insertion for the Treatment of Malignant Esophageal Obstruction, after Propensity Score Matching
Comment published on 27 November 2020, see Nutrients 2020, 12(12), 3642.
Article

Vitamin D Deficiency and Outcome of COVID-19 Patients

1
Department of Internal Medicine V, University of Heidelberg, 69121 Heidelberg, Germany
2
Department of Internal Medicine IV, University of Heidelberg, 69121 Heidelberg, Germany
*
Author to whom correspondence should be addressed.
Nutrients 2020, 12(9), 2757; https://doi.org/10.3390/nu12092757
Received: 9 August 2020 / Revised: 1 September 2020 / Accepted: 9 September 2020 / Published: 10 September 2020
(This article belongs to the Section Micronutrients and Human Health)
Infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses an enormous challenge to health care systems throughout the world. Without causal treatment, identification of modifiable prognostic factors may help to improve outcomes. To explore possible associations of vitamin D (VitD) status with disease severity and survival, we studied 185 patients diagnosed with coronavirus disease 2019 (COVID-19) and treated at our center. VitD status at first presentation was assessed retrospectively using accredited laboratory methods. VitD deficiency was defined as serum total 25-hydroxyvitamin D level < 12 ng/mL (<30 nM). Primary endpoint was severe course of disease (i.e., need for invasive mechanical ventilation and/or death, IMV/D). Within a median observation period of 66 days (range 2–92), 23 patients required IMV. A total of 28 patients had IMV/D, including 16 deaths. Ninety-three (50%) patients required hospitalization (inpatient subgroup). A total of 41 (22%) patients were VitD deficient. When adjusted for age, gender, and comorbidities, VitD deficiency was associated with higher risk of IMV/D and death (HR 6.12, 95% CI 2.79–13.42, p < 0.001 and HR 14.73, 95% CI 4.16–52.19, p < 0.001, respectively). Similar correlations were observed in the inpatient subgroup. Our study demonstrates an association between VitD deficiency and severity/mortality of COVID-19, highlighting the need for interventional studies on VitD supplementation in SARS-CoV-2 infected individuals. View Full-Text
Keywords: vitamin D; SARS-CoV-2; COVID-19; outcome; severity; retrospective vitamin D; SARS-CoV-2; COVID-19; outcome; severity; retrospective
Show Figures

Figure 1

MDPI and ACS Style

Radujkovic, A.; Hippchen, T.; Tiwari-Heckler, S.; Dreher, S.; Boxberger, M.; Merle, U. Vitamin D Deficiency and Outcome of COVID-19 Patients. Nutrients 2020, 12, 2757. https://doi.org/10.3390/nu12092757

AMA Style

Radujkovic A, Hippchen T, Tiwari-Heckler S, Dreher S, Boxberger M, Merle U. Vitamin D Deficiency and Outcome of COVID-19 Patients. Nutrients. 2020; 12(9):2757. https://doi.org/10.3390/nu12092757

Chicago/Turabian Style

Radujkovic, Aleksandar, Theresa Hippchen, Shilpa Tiwari-Heckler, Saida Dreher, Monica Boxberger, and Uta Merle. 2020. "Vitamin D Deficiency and Outcome of COVID-19 Patients" Nutrients 12, no. 9: 2757. https://doi.org/10.3390/nu12092757

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop